🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07279545
Recruiting Not applicable

The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding

NCT07279545 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-17
Last updated
2025-12-12

Condition(s) studied

Postpartum Hemorrhage

Investigational drug(s) / intervention(s)

Placental cord drainage

Placental cord drainage: Placental cord drainage is the process of clamping and cutting the umbilical cord after the birth of the baby, then opening the clamp at the maternal end of the cord and allowing the blood in the placenta to flow outward (Soltani et al, 2011; Vasconcelos et al, 2018; Pandey et al, 2019; Upadya et al, 2019; Chaudhary et al, 2020; Kazı et al, 2020; Mittal et al, 2020; Nabıl and Marzouk, 2020; Mansour et al, 2021; El Sayed et al, 2021; Karimi et al, 2022; Wedn and Hassanin, 2022).

Study summary

The aim of the study was to evaluate the effect of controlled placental cord drainage by opening the clamp at the maternal end after the umbilical cord is cut during birth on the duration of the third stage of labor (departure of the placenta), the amount of blood loss in the third stage, the amount of bleeding in the 2nd hour postpartum, and the development of postpartum complications.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * No problem speaking and understanding Turkish * Low-risk pregnant women * Vertex presentation * 37-41st weeks of gestation * There are no complications in the mother or the baby that prevent normal birth. * The VAS score for the pain felt by the pregnant woman at the time of admission to the study must be less than 3 (to show that the pregnant women were accepted into the study at a time when their pain was at its lowest and their decision-making ability was at a relatively good level) Exclusion Criteria: * History of postpartum hemorrhage * History of postpartum hemorrhage in mother or sister * Birth interval less than 2 years * Anticoagulant use during pregnancy * Smoking during pregnancy * Those with low Hb values (Hb\<11gr/dL) * Hematocrit \<30

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zonguldak Maternity and Child Diseases Hospital Zonguldak Zonguldak/Centre Recruiting

More Saglik Bilimleri Universitesi Gulhane Tip Fakultesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07279545 on ClinicalTrials.gov ↗ ← All trials in Turkey